141 related articles for article (PubMed ID: 24680865)
1. Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.
Imanishi S; Umezu T; Ohtsuki K; Kobayashi C; Ohyashiki K; Ohyashiki JH
Biochem Pharmacol; 2014 Jun; 89(3):361-9. PubMed ID: 24680865
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A).
Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS
Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008
[TBL] [Abstract][Full Text] [Related]
3. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status.
Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS
Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909
[TBL] [Abstract][Full Text] [Related]
6. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
Pulukuri SM; Rao JS
Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.
Ko JC; Chiu HC; Syu JJ; Jian YJ; Chen CY; Jian YT; Huang YJ; Wo TY; Lin YW
Biochem Pharmacol; 2014 Mar; 88(1):119-27. PubMed ID: 24447935
[TBL] [Abstract][Full Text] [Related]
9. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant haematopoietic cell lines treated with 5-azacytidine.
Stankov K; Bogdanovic G; Kojic V; Stankov S; Jojic N; Popovic L; Popovic S
J BUON; 2011; 16(1):116-22. PubMed ID: 21674861
[TBL] [Abstract][Full Text] [Related]
11. Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines.
Tsujioka T; Yokoi A; Uesugi M; Kishimoto M; Tochigi A; Suemori S; Tohyama Y; Tohyama K
Exp Hematol; 2013 Feb; 41(2):189-97. PubMed ID: 23085465
[TBL] [Abstract][Full Text] [Related]
12. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance to azacitidine in human leukemia cell lines.
Sripayap P; Nagai T; Uesawa M; Kobayashi H; Tsukahara T; Ohmine K; Muroi K; Ozawa K
Exp Hematol; 2014 Apr; 42(4):294-306.e2. PubMed ID: 24368162
[TBL] [Abstract][Full Text] [Related]
14. Silencing HO-1 sensitizes SKM-1 cells to apoptosis induced by low concentration 5-azacytidine through enhancing p16 demethylation.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Lu T; Cao L
Int J Oncol; 2015 Mar; 46(3):1317-27. PubMed ID: 25585641
[TBL] [Abstract][Full Text] [Related]
15. LW-214, a newly synthesized flavonoid, induces intrinsic apoptosis pathway by down-regulating Trx-1 in MCF-7 human breast cells.
Pan D; Li W; Miao H; Yao J; Li Z; Wei L; Zhao L; Guo Q
Biochem Pharmacol; 2014 Feb; 87(4):598-610. PubMed ID: 24374359
[TBL] [Abstract][Full Text] [Related]
16. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of 5-azacytidine and NF-κB inhibitor DHMEQ on apoptosis induction in myeloid leukemia cells.
Togano T; Nakashima M; Watanabe M; Umezawa K; Watanabe T; Higashihara M; Horie R
Oncol Res; 2012; 20(12):571-7. PubMed ID: 24139415
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells.
Zhang H; Huang H; Feng X; Song H; Zhang Z; Shen A; Qiu X
Theranostics; 2020; 10(3):1046-1059. PubMed ID: 31938050
[TBL] [Abstract][Full Text] [Related]
19. Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells.
Ko JC; Wang TJ; Chang PY; Syu JJ; Chen JC; Chen CY; Jian YT; Jian YJ; Zheng HY; Chen WC; Lin YW
Biochem Pharmacol; 2015 Oct; 97(3):331-40. PubMed ID: 26212550
[TBL] [Abstract][Full Text] [Related]
20. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
